(Q33418574)

26 July 2017

Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy (English)

1 reference

26 July 2017

1 reference

1 reference

Gregory M Cote

8

0 references

George D Demetri

13

object named as

George D Demetri

1 reference

26 July 2017

Edwin Choy

1

1 reference

26 July 2017

James E Butrynski

2

1 reference

26 July 2017

David C Harmon

3

1 reference

26 July 2017

Jeffrey A Morgan

4

1 reference

26 July 2017

Suzanne George

5

1 reference

26 July 2017

Andrew J Wagner

6

1 reference

26 July 2017

David D'Adamo

7

1 reference

26 July 2017

Yael Flamand

9

1 reference

26 July 2017

Cyril H Benes

10

1 reference

26 July 2017

Daniel A Haber

11

1 reference

26 July 2017

Jose M Baselga

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

5 November 2014

1 reference

26 July 2017

1 reference

26 July 2017

14

1 reference

26 July 2017

813

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-14-813

26 July 2017

0 references

cites work

The biology of ewing sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

Systematic identification of genomic markers of drug sensitivity in cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

Survival after recurrence of Ewing's sarcoma family of tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

Optimal two-stage designs for phase II clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4230717

Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-813

Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-813

Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-813

Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-813

Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25374341

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25374341

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-14-813

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference